Merck Net Income 2006-2019 | MKGAF

Merck annual/quarterly net income history and growth rate from 2006 to 2019. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Merck net income for the quarter ending March 31, 2019 was $0.215B, a 48.79% decline year-over-year.
  • Merck net income for the twelve months ending March 31, 2019 was $3.780B, a 34.88% increase year-over-year.
  • Merck annual net income for 2018 was $3.985B, a 35.59% increase from 2017.
  • Merck annual net income for 2017 was $2.939B, a 63.03% increase from 2016.
  • Merck annual net income for 2016 was $1.803B, a 45.72% increase from 2015.
Merck Annual Net Income
(Millions of US $)
2018 $3,985
2017 $2,939
2016 $1,803
2015 $1,237
2014 $1,548
2013 $1,606
2012 $745
2011 $876
2010 $839
2009 $511
2008 $540
2007 $4,799
2006 $1,235
2005 $820
Merck Quarterly Net Income
(Millions of US $)
Q1 2019 $215
Q4 2018 $2,876
Q3 2018 $395
Q2 2018 $295
Q1 2018 $419
Q4 2017 $1,162
Q3 2017 $758
Q2 2017 $463
Q1 2017 $555
Q4 2016 $288
Q3 2016 $510
Q2 2016 $352
Q1 2016 $652
Q4 2015 $138
Q3 2015 $407
Q2 2015 $380
Q1 2015 $321
Q4 2014 $313
Q3 2014 $331
Q2 2014 $405
Q1 2014 $446
Q4 2013 $382
Q3 2013 $450
Q2 2013 $419
Q1 2013 $345
Q4 2012 $350
Q3 2012 $232
Q2 2012 $-78
Q1 2012 $222
Q4 2011 $178
Q3 2011 $321
Q2 2011 $-124
Q1 2011 $466
Q4 2010 $89
Q3 2010 $272
Q2 2010 $224
Q1 2010 $255
Q4 2009 $82
Q3 2009 $206
Q2 2009 $148
Q1 2009 $75
Q4 2008 $-444
Q3 2008 $302
Q2 2008 $324
Q1 2008 $358
Q4 2007 $4,645
Q3 2007 $50
Q2 2007 $115
Q1 2007 $-11
Q4 2006 $169
Q3 2006 $184
Q2 2006 $664
Q1 2006 $218
Q4 2005 $129
Q3 2005 $221
Q2 2005 $313
Q1 2005 $157
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $14.630B $17.522B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $62.561B 9.89
Zoetis (ZTS) United States $58.852B 35.20
Astellas Pharma (ALPMY) Japan $32.261B 16.11
Eisai (ESALY) Japan $20.942B 40.38
Grifols, S.A (GRFS) Spain $15.594B 20.43
UCB SA (UCBJF) Belgium $15.483B 0.00
Neurocrine Biosciences (NBIX) United States $10.430B 492.39
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Ionis Pharmaceuticals (IONS) United States $8.678B 17.58
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.380B 10.70
Catalent (CTLT) United States $7.634B 31.06
IPSEN SA ADR (IPSEY) France $7.374B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $6.529B 98.87
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.226B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $4.932B 17.73
FibroGen (FGEN) United States $4.127B 121.28
United Therapeutics (UTHR) United States $4.059B 0.00
Nektar Therapeutics (NKTR) United States $3.800B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.641B 13.31
Sage Therapeutics (SAGE) United States $3.558B 0.00
Evotec AG (EVTCY) Germany $3.498B 57.24
PTC Therapeutics (PTCT) United States $2.966B 0.00
ArQule (ARQL) United States $2.439B 0.00
Heron Therapeutics (HRTX) United States $2.304B 0.00
Xencor (XNCR) United States $2.160B 65.65
Portola Pharmaceuticals (PTLA) United States $2.113B 0.00
Zogenix (ZGNX) United States $2.093B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.943B 61.95
Pacira Pharmaceuticals (PCRX) United States $1.900B 56.22
Tilray (TLRY) Canada $1.829B 0.00
ChemoCentryx (CCXI) United States $1.812B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.741B 0.00
USANA Health Sciences (USNA) United States $1.621B 17.30
Corcept Therapeutics (CORT) United States $1.551B 18.85
Enanta Pharmaceuticals (ENTA) United States $1.268B 28.95
CLINIGEN GP (CLIGF) United Kingdom $1.245B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.176B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.130B 0.00
Karyopharm Therapeutics (KPTI) United States $1.049B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.041B 7.10
Radius Health (RDUS) United States $1.019B 0.00
Endo (ENDP) Ireland $0.996B 1.83
Aerie Pharmaceuticals (AERI) United States $0.993B 0.00
Flexion Therapeutics (FLXN) United States $0.794B 0.00
Akebia Therapeutics (AKBA) United States $0.747B 0.00
Collegium Pharmaceutical (COLL) United States $0.684B 0.00
TherapeuticsMD (TXMD) United States $0.643B 0.00
Dermira (DERM) United States $0.636B 0.00
ImmunoGen (IMGN) United States $0.545B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.530B 0.00
Translate Bio (TBIO) United States $0.508B 0.00
Ardelyx (ARDX) United States $0.472B 0.00
Organogenesis Holdings (ORGO) United States $0.461B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.443B 53.75
Aptorum Group (APM) Hong Kong, SAR China $0.442B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.435B 18.74
Harpoon Therapeutics (HARP) United States $0.431B 0.00
Molecular Templates (MTEM) United States $0.412B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.410B 0.00
OptiNose (OPTN) United States $0.394B 0.00
Indivior (INVVY) United States $0.389B 1.41
Rigel Pharmaceuticals (RIGL) United States $0.382B 0.00
Siga Technologies (SIGA) United States $0.379B 8.65
Recro Pharma (REPH) United States $0.378B 0.00
DURECT (DRRX) United States $0.367B 0.00
Innate Pharma SA (IPHYF) France $0.358B 0.00
Lannett Co Inc (LCI) United States $0.354B 4.12
Corbus Pharmaceuticals Holdings (CRBP) United States $0.318B 0.00
Jounce Therapeutics (JNCE) United States $0.304B 4.06
Rafael Holdings (RFL) United States $0.303B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.285B 0.00
KalVista Pharmaceuticals (KALV) United States $0.276B 0.00
Concordia (CXRXF) Canada $0.269B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.267B 0.00
Calithera Biosciences (CALA) United States $0.243B 0.00
GlycoMimetics (GLYC) United States $0.242B 0.00
Xeris Pharmaceuticals (XERS) United States $0.241B 0.00
Aquestive Therapeutics (AQST) United States $0.193B 0.00
Ocular Therapeutix (OCUL) United States $0.192B 0.00
Nature's Sunshine Products (NATR) United States $0.191B 32.93
AcelRx Pharmaceuticals (ACRX) United States $0.190B 0.00
Concert Pharmaceuticals (CNCE) United States $0.188B 0.00
Taiwan Liposome (TLC) Taiwan $0.178B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.170B 0.00
IMV INC (IMV) Canada $0.157B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.146B 0.00
MEI Pharma (MEIP) United States $0.144B 0.00
Redhill Biopharma (RDHL) Israel $0.136B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.130B 0.00
CannTrust Holdings (CTST) Canada $0.116B 0.00
CV Sciences (CVSI) United States $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.094B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.088B 0.00
Capnia (SLNO) United States $0.084B 0.00
MediWound (MDWD) Israel $0.082B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.079B 23.64
Otonomy (OTIC) United States $0.077B 0.00
Champions Oncology (CSBR) United States $0.077B 0.00
Aclaris Therapeutics (ACRS) United States $0.075B 0.00
Neos Therapeutics (NEOS) United States $0.074B 0.00
PolarityTE (PTE) United States $0.073B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.071B 0.00
CTI BioPharma (CTIC) United States $0.070B 0.00
Infinity Pharmaceuticals (INFI) United States $0.067B 0.00
Nivalis Therapeutics (ALPN) United States $0.067B 0.00
Pharmaxis (PXSLY) Australia $0.065B 0.00
Forward Pharma (FWP) Denmark $0.065B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.063B 0.00
RENEURON GP (RNUGF) United Kingdom $0.062B 0.00
Genocea Biosciences (GNCA) United States $0.059B 0.00
Novan (NOVN) United States $0.059B 0.00
Natural Alternatives (NAII) United States $0.057B 14.29
Opiant Pharmaceuticals (OPNT) United States $0.057B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.056B 0.00
Medicure (MCUJF) Canada $0.055B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.053B 0.00
Mast Therapeutics (SVRA) United States $0.050B 0.00
AgeX Therapeutics (AGE) United States $0.049B 0.00
SCYNEXIS (SCYX) United States $0.046B 0.00
ElectroCore (ECOR) United States $0.046B 0.00
Iterum Therapeutics (ITRM) Ireland $0.044B 0.00
IsoRay (ISR) United States $0.042B 0.00
Opexa Therapeutics (ACER) United States $0.040B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.038B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.032B 0.00
Jaguar Animal Health (JAGX) United States $0.030B 0.00
PharmAthene (ALT) United States $0.028B 0.00
Shineco (TYHT) China $0.028B 0.00
India Globalization Capital (IGC) United States $0.027B 0.00
Biomerica (BMRA) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.026B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
Cardiome Pharma (CORV) Canada $0.023B 0.00
Bio-Path Holdings (BPTH) United States $0.022B 0.00
China SXT Pharmaceuticals (SXTC) China $0.022B 0.00
Melinta Therapeutics (MLNT) United States $0.022B 0.00
Heat Biologics (HTBX) United States $0.016B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Flex Pharma (SLRX) United States $0.015B 0.00
VAXART, INC (VXRT) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Vical (BBI) United States $0.013B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
Lipocine (LPCN) United States $0.009B 0.00
HANCOCK JAFFE (HJLI) United States $0.008B 0.00
Achieve Life Sciences (ACHV) United States $0.007B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Hemispherx BioPharma (AIM) United States $0.003B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00